Efficacy and safety of an expanded dulaglutide dose range: a phase 2, placebo-controlled trial in patients with type 2 diabetes using metformin
Tirzepatide (Mounjaro, Zepbound) Mounjaro is approved for type 2 diabetes
Your work schedule affects which tracking approach will last beyond week two
Then of course some may be metabolically healthy yet obese per BMI standards and some may be normal weight per BMI and yet metabolically obese and unhealthy
5 Randomized data suggest that intermittent energy restriction achieves similar HbA1c reductions to continuous energy restriction, with no clear between-group differences in GLP-1 concentrations, so any specific GLP-1 benefit of IF remains uncertain
For researchers and self-directed users, SeekPeptides provides comprehensive protocol guides, dosage calculators , and evidence-based resources to supplement professional medical guidance